Results 1 to 10 of about 528,207 (389)

Pituitary metastases from neuroendocrine neoplasms: case report and narrative review [PDF]

Pituitary, 2021
Abstract Purpose Pituitary metastases (PM) are uncommon findings and are mainly derived from breast and lung cancers. No extensive review of PM from neuroendocrine neoplasms (NENs) is on record. Here we describe a clinical case of PM from pancreatic NEN and review the clinical features of PM from NENs reported in the ...
Ragni A., Nervo A., Papotti M., Prencipe N., Retta F., Rosso D., Cacciani M., Zamboni G., Zenga F., Uccella S., Cassoni P., Gallo M., Piovesan A., Arvat E.   +13 more
semanticscholar   +7 more sources

Treatment of pituitary neoplasms with temozolomide [PDF]

Cancer, 2010
AbstractTemozolomide, an orally administered alkylating agent, is used to treat malignant gliomas. Recent reports also have documented its efficacy in the treatment of pituitary adenomas and carcinomas. Temozolomide methylates DNA and thereby exhibits an antitumor effect.
Ricardo V. Lloyd, Humberto Uribe, Michael D. Cusimano, Ricardo Gonzalez, Leon D. Ortiz, Bernd W. Scheithauer, Kalman Kovacs, Eva Horvath, Queenie Lau, Luis V. Syro   +9 more
semanticscholar   +5 more sources

Analysis of risk factors of pituitary neoplasms invading the sphenoidal sinus. [PDF]

Medicine (Baltimore), 2023
High-resolution computed tomography (HR-CT) can more effectively discern the relationship between pituitary neoplasms (PNs) and neighboring anatomical structures. Moreover, pathological features can facilitate a more accurate determination of the growth pattern of PNs. Consequently, integrating imaging and pathological data might enhance our predictive
Luo B, Ren H, Wang Y, Ma L, Yu M, Ma Y, Yin L, Huang Y.   +7 more
europepmc   +4 more sources

Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time? [PDF]

Journal of the Endocrine Society, 2021
Abstract The WHO Classification of Endocrine Tumours designates pituitary neoplasms as adenomas. A proposed nomenclature change to pituitary neuroendocrine tumors (PitNETs) has been met with concern by some stakeholder groups. The Pituitary Society coordinated the Pituitary Neoplasm Nomenclature (PANOMEN) workshop to address the topic ...
Ken Ho, Maria Fleseriu, Ursula Kaiser, Roberto Salvatori, Thierry Brue, M Beatriz Lopes, Pamela Kunz, Mark Molitch, Sally A Camper, Mônica Gadelha, Luis V Syro, Edward Laws, Martin Reincke, Hiroshi Nishioka, Ashley Grossman, Ariel Barkan, Felipe Casanueva, John Wass, Adam Mamelak, Laurence Katznelson, Aart J van der Lely, Sally Radovick, Martin Bidlingmaier, Margaret Boguszewski, Jens Bollerslev, Andrew R Hoffman, Nelson Oyesiku, Gerald Raverot, Anat Ben-Shlomo, Rob Fowkes, Ilan Shimon, Hidenori Fukuoka, Alberto M Pereira, Yona Greenman, Anthony P Heaney, Mark Gurnell, Gudmundur Johannsson, Robert Y Osamura, Michael Buchfelder, Maria Chiara Zatelli, Marta Korbonits, Philippe Chanson, Nienke Biermasz, David R Clemmons, Niki Karavitaki, Marcello D Bronstein, Peter Trainer, Shlomo Melmed   +47 more
semanticscholar   +12 more sources

Nonneuroendocrine Neoplasms of the Pituitary Region [PDF]

The Journal of Clinical Endocrinology & Metabolism, 2019
Although most sellar lesions are related to pituitary adenomas, the region gives rise to a variety of neoplasms that can be associated with substantial morbidity and/or mortality.Information from reviews and guidelines of relevant societies dealing with such neoplasms, as well as articles that have provided new developments that made important ...
Harpal S. Randeva, Dionysia Kolomodi, Ashley B. Grossman, Gregory Kaltsas, Gregory Kaltsas   +4 more
openaire   +4 more sources

Infiltrating pituitary neoplasms in the rat [PDF]

Laboratory Animals, 1979
Summary 11 cases of spontaneous pituitary neoplasms in rats, which showed infiltration into brain tissue, are reported. This represents an incidence of about 0·42%.
C. Gopinath, G. Magnusson, S. K. Majeed
openaire   +4 more sources

The Molecular Pathogenesis of Pituitary Adenomas: An Update [PDF]

Endocrinology and Metabolism, 2013
Pituitary tumors represent the most common intracranial neoplasms accompanying serious morbidity through mass effects and inappropriate secretion of pituitary hormones. Understanding the etiology of pituitary tumorigenesis will facilitate the development
Jiang, Xiaobing, Zhang, Xun
core   +4 more sources

Restored vision in a young dog following corticosteroid treatment of presumptive hypophysitis [PDF]

, 2016
Background: Hypophysitis is an umbrella term for a group of disorders involving inflammation of the pituitary gland. A rare occurrence in humans, hypophysitis can produce a range of clinical signs including (but not limited to) visual deficits and ...
Liuti, Tiziana, Marioni-Henry, Katia, Rzechorzek, Nina Marie, Stalin, Catherine   +3 more
core   +2 more sources

Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma. [PDF]

, 2015
Adamantinomatous craniopharyngiomas (ACPs) are the most common pituitary tumours in children. Although histologically benign, these are clinically aggressive tumours, difficult to manage and associated with poor quality of life for the patients.
Martinez-Barbera, JP
core   +1 more source

Succinate dehydrogenase (SDH)-deficient renal carcinoma:a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients [PDF]

, 2014
Succinate dehydrogenase (SDH)-deficient renal carcinoma has been accepted as a provisional entity in the 2013 International Society of Urological Pathology Vancouver Classification.
Belinsky, Cascon, Cascon, Chou, Dwight, Dwight, Eng, Fairchild, Fishbein, Fleming, Gaal, Gill, Gill, Gill, Gill, Gill, Gill, Gill, Gill, Gimm, Henderson, Housley, Janeway, Jasperson, Korpershoek, Malinoc, Miettinen, Miettinen, Miettinen, Neumann, Ni, Oudijk, Paik, Papathomas, Ricketts, Ricketts, Said-Al-Naief, Schimke, Solis, Srigley, Srirangalingam, Srirangalingam, van Nederveen, van Nederveen, Vanharanta, Wagner, Xekouki   +46 more
core   +3 more sources